AI-generated summary
The authors report a randomized trial of 60 patients with reversible pulpitis in permanent molars, comparing photobiomodulation therapy alone or combined with platelet-rich fibrin or mineral trioxide aggregate after direct pulp capping. Groups receiving photobiomodulation showed significant pain reduction in the first and second weeks, and cone-beam computed tomography showed greater dentin bridge development, with the combination with platelet-rich fibrin associated with the best results. Findings are limited to a single small trial with three-group comparisons.
- Participants
- 60
- Who or what was studied
- Patients aged 17 to 45 years with reversible pulpitis in permanent molars
- Limits stated in the abstract
- The abstract reports a single trial of 20 patients per group with follow-up limited to 12 months and does not describe wavelengths or device parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.